Evidence map›Paper›PMID 33066633›Full record

ArticleInternational journal of molecular sciences2020

MGMT Promoter Methylation and IDH1 Mutations Do Not Affect [

Andrea Cimini, Agostino Chiaravalloti, Maria Ricci, Veronica Villani, Gianluca Vanni, Orazio Schillaci

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Andrea CiminiDepartment of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.ORCID 0000-0003-0533-2947
Agostino ChiaravallotiDepartment of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-8017-8858
Maria RicciDepartment of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-9277-6337
Veronica VillaniNeuro-Oncology Unit, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Gianluca VanniDepartment of Surgical Science, Tor Vergata (PTV) University, 00133 Rome, Italy.
Orazio SchillaciDepartment of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.
University of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of our study was to investigate the effects of methylation of

Indexed as

DNA MethylationMutationPositron Emission Tomography Computed TomographyAdultBrain NeoplasmsDihydroxyphenylalanineDNA Modification MethylasesDNA Repair EnzymesFemaleGliomaHumansIsocitrate DehydrogenaseMaleMiddle AgedPromoter Regions, GeneticRadiopharmaceuticalsDihydroxyphenylalanineDNA Modification MethylasesDNA Repair Enzymesfluorodopa F 18IDH1 protein, humanIsocitrate DehydrogenaseMGMT protein, humanRadiopharmaceuticalsTumor Suppressor Proteins[18F]FDOPAIDH1 mutationMGMT promoter methylationnuclear medicinepositron emission tomographyPrimary brain tumorsradiopharmaceuticals

Identifiers

PMID33066633
PMCPMC7589068
OpenAlexW3092869448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.